AE Wealth Management LLC Trims Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Posted by Defense World Staff on Jun 29th, 2023

AE Wealth Management LLC trimmed its position in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 8.4% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 28,621 shares of the company’s stock after selling 2,630 shares during the quarter. AE Wealth Management LLC’s holdings in HCA Healthcare were worth $7,547,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of the company. Arkadios Wealth Advisors boosted its position in HCA Healthcare by 3.4% during the 4th quarter. Arkadios Wealth Advisors now owns 1,280 shares of the company’s stock valued at $307,000 after acquiring an additional 42 shares in the last quarter. Global Assets Advisory LLC boosted its position in HCA Healthcare by 3.6% during the 4th quarter. Global Assets Advisory LLC now owns 1,227 shares of the company’s stock valued at $294,000 after acquiring an additional 43 shares in the last quarter. HMS Capital Management LLC boosted its position in shares of HCA Healthcare by 0.7% in the 1st quarter. HMS Capital Management LLC now owns 6,631 shares of the company’s stock worth $1,748,000 after purchasing an additional 43 shares in the last quarter. Geneos Wealth Management Inc. boosted its position in shares of HCA Healthcare by 56.4% in the 4th quarter. Geneos Wealth Management Inc. now owns 122 shares of the company’s stock worth $29,000 after purchasing an additional 44 shares in the last quarter. Finally, Northeast Financial Consultants Inc boosted its position in shares of HCA Healthcare by 1.9% in the 3rd quarter. Northeast Financial Consultants Inc now owns 2,378 shares of the company’s stock worth $437,000 after purchasing an additional 45 shares in the last quarter. 62.86% of the stock is owned by institutional investors.

HCA Healthcare Trading Up 0.7 %

Shares of HCA Healthcare stock opened at $299.56 on Thursday. The company has a market capitalization of $82.44 billion, a P/E ratio of 15.02, a P/E/G ratio of 1.86 and a beta of 1.64. The company has a debt-to-equity ratio of 157.23, a quick ratio of 1.04 and a current ratio of 1.23. The company has a fifty day moving average of $278.74 and a 200 day moving average of $262.78. HCA Healthcare, Inc. has a fifty-two week low of $164.47 and a fifty-two week high of $299.78.

HCA Healthcare (NYSE:HCA – Free Report) last released its quarterly earnings data on Friday, April 21st. The company reported $4.93 EPS for the quarter, beating the consensus estimate of $3.99 by $0.94. HCA Healthcare had a net margin of 9.42% and a negative return on equity of 1,157.58%. The business had revenue of $15.59 billion during the quarter, compared to the consensus estimate of $15.26 billion. During the same quarter in the prior year, the firm earned $4.12 EPS. The business’s revenue was up 4.3% on a year-over-year basis. On average, sell-side analysts anticipate that HCA Healthcare, Inc. will post 18.1 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, June 30th. Shareholders of record on Friday, June 16th will be issued a dividend of $0.60 per share. This represents a $2.40 annualized dividend and a dividend yield of 0.80%. The ex-dividend date of this dividend is Thursday, June 15th. HCA Healthcare’s dividend payout ratio (DPR) is presently 12.04%.

Insider Activity at HCA Healthcare

In related news, SVP P. Martin Paslick sold 3,034 shares of the stock in a transaction dated Tuesday, April 4th. The shares were sold at an average price of $265.00, for a total value of $804,010.00. Following the completion of the transaction, the senior vice president now owns 24,643 shares of the company’s stock, valued at approximately $6,530,395. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In related news, SVP Kathryn A. Torres sold 4,473 shares of the stock in a transaction dated Monday, April 24th. The shares were sold at an average price of $288.38, for a total value of $1,289,923.74. Following the sale, the senior vice president now directly owns 22,243 shares of the company’s stock, valued at approximately $6,414,436.34. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP P. Martin Paslick sold 3,034 shares of the stock in a transaction dated Tuesday, April 4th. The stock was sold at an average price of $265.00, for a total transaction of $804,010.00. Following the completion of the sale, the senior vice president now directly owns 24,643 shares in the company, valued at $6,530,395. The disclosure for this sale can be found here. In the last quarter, insiders sold 12,733 shares of company stock valued at $3,518,389. Insiders own 1.60% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have recently commented on the company. Truist Financial boosted their price target on HCA Healthcare from $325.00 to $340.00 in a research report on Tuesday, June 20th. Cantor Fitzgerald assumed coverage on HCA Healthcare in a research report on Thursday, April 20th. They issued an “overweight” rating and a $304.00 price objective on the stock. Stephens reaffirmed an “overweight” rating and issued a $283.00 price objective on shares of HCA Healthcare in a research report on Friday, April 21st. Sanford C. Bernstein upped their price objective on HCA Healthcare from $310.00 to $345.00 in a research report on Tuesday, April 25th. Finally, Credit Suisse Group boosted their target price on shares of HCA Healthcare from $282.00 to $311.00 in a research note on Monday, April 24th. One analyst has rated the stock with a sell rating, two have issued a hold rating, fifteen have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $299.83.

HCA Healthcare Profile

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, provides health care services in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.